Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next‐generation sequencing and dual‐fusion FISH analysis-Reference-Cited by-同舟云学术

Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next‐generation sequencing and dual‐fusion FISH analysis

Published:2021-11-12 Issue:3 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Raghunandan Sharmila¹^ORCID,Jain Juhi¹,Saxe Debra²,Pauly Melinda¹^ORCID,Aljudi Ahmed A.³,Ketterling Rhett P.⁴,Carter Alexis B.³,Raikar Sunil S.¹^ORCID

Affiliation:

1. Department of Pediatrics, Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta and Emory University Atlanta Georgia USA

2. Department of Pathology and Laboratory Medicine Emory University School of Medicine Atlanta Georgia USA

3. Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta Atlanta Georgia USA

4. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine Rochester Minnesota USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29428

Reference13 articles.

1. The MLL recombinome of acute leukemias in 2017

2. Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention

3. Prognostic Significance of 11q23/MLL Fusion Partners in Children with Acute Myeloid Leukemia (AML) - Results from the Children's Oncology Group (COG) Trial AAML0531

4. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy

5. Revised risk stratification criteria for children with newly diagnosed acute myeloid leukemia: a report from the Children's Oncology Group;Cooper TM;Blood,2017